0000000000011785

AUTHOR

Maria Jose Fabia

showing 7 related works from this author

THE METABOLIC SYNDROME IN HYPERTENSION

2019

The metabolic syndrome (MS) is currently considered to be a cluster of metabolic and cardiovascular risk factors including blood pressure elevation. A higher risk to develop hypertension in MS subjects with high-normal blood pressure has been observed and, when hypertension is established, seems to be what confers a higher cardiovascular risk on top of the risk induced by blood pressure elevation. Therefore, assessment of MS components can result in clinical utility strategy to manage hypertension based on individual risk. The main mechanisms for blood pressure elevation include overactivity of the sympathetic and the reninangiotensin system, abnormal renal sodium handling, and endothelial …

medicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.diseaseInsulin resistanceBlood pressureEndocrinologyInternal medicineDiabetes mellitusPathophysiology of hypertensionAortic pressureCardiologyMedicineEndothelial dysfunctionMetabolic syndromebusinessLipid profile
researchProduct

Efficacy in angiotensin receptor blockade: a comparative review of data with olmesartan

2009

A range of angiotensin II receptor blockers (ARB) is available, and analyses suggest there are differences between agents in terms of antihypertensive efficacy and 24-hour blood pressure control.This review assesses the data comparing olmesartan with other ARBs in terms of blood pressure reductions, goal achievement, 24-hour control and speed of onset. Olmesartan seems to have a more favourable efficacy profile relative to standard doses of the ARBs used in comparative studies; results consistent with the high degree of blockade of the angiotensin II type 1 receptor for olmesartan.Taken together, there might be differences between ARBs regarding their blood pressure lowering efficacy, and …

Medicine (General)Angiotensin receptorReceptors AngiotensinAngiotensin Receptor Antagonistsbusiness.industryImidazolesTetrazolesBlood PressurePharmacologyAngiotensin IIBlockadeAngiotensin Receptor AntagonistsR5-920Treatment OutcomeEndocrinologyBlood pressurePharmacotherapyRenin–angiotensin systemInternal MedicineHumansMedicineDrug Therapy CombinationbusinessOlmesartanmedicine.drugJournal of the Renin-Angiotensin-Aldosterone System
researchProduct

Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension.

2006

The objective of the present study was to analyze the impact of metabolic syndrome (MS) and its individual components on oxidative stress (OX) and on the activity of antioxidant enzymes of patients with essential hypertension. One hundred and eighty-seven hypertensives, 127 (61.9%) of them having criteria for MS according to the International Diabetes Federation criteria and 30 healthy normotensive subjects were included. OX status was assessed by measuring glutathione oxidized/glutathione reduced and reactive oxygen species-induced byproducts of lipid peroxidation, malondialdehide, and DNA damage, 8-oxo-dG genomic and mitochondrial. Antioxidant enzymatic activity of Cu/Zn extracellular-sup…

AdultMalemedicine.medical_specialtyGPX1Antioxidantmedicine.medical_treatmentmedicine.disease_causeEssential hypertensionPeripheral blood mononuclear cellLipid peroxidationchemistry.chemical_compoundInternal medicineInternal MedicinemedicineHumansMetabolic Syndromebiologybusiness.industryGlutathioneMiddle Agedmedicine.diseaseOxidative StressEndocrinologychemistryCatalaseHypertensionbiology.proteinFemalebusinessOxidative stressJournal of human hypertension
researchProduct

Should we look for silent pulmonary embolism in patients with deep venous thrombosis?

2014

Background Asymptomatic or silent pulmonary embolism (S-PE) in patients with deep vein thrombosis has been the focus of numerous publications with the objective of determining the incidence of S-PE and assessing whether its existence has any clinical or therapeutic consequences that outweigh the risks associated with the diagnostic tests performed and the increased healthcare costs. The objectives were to assess the incidence of S-PE using computed tomography angiogram (CTA), to understand the epidemiological factors that might trigger embolism, and to assess whether D-dimer (DD) predicts the existence of S-PE’s. Methods A prospective and consecutive assessment of 103 hospitalized patients …

AdultMalemedicine.medical_specialtyAdolescentDeep veinAsymptomaticFibrin Fibrinogen Degradation ProductsYoung AdultDeep vein thrombosisHumansMedicineProspective StudiesProspective cohort studyAgedAngiologyAged 80 and overVenous Thrombosisbusiness.industryIncidencePulmonary embolismMiddle Agedmedicine.diseaseThrombosisPulmonary embolismRadiographyVenous thrombosismedicine.anatomical_structureEmbolismD-dimerAsymptomatic DiseasesFemaleRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesResearch ArticleBMC Cardiovascular Disorders
researchProduct

Factores que influyen en la diferencia de medida de presión arterial entre el método auscultatorio y el oscilométrico

2006

Fundamento y objetivo El metodo auscultatorio mediante esfigmomanometro de mercurio esta siendo sustituido por otros metodos de medida de presion arterial, de los que el mas utilizado es el oscilometrico. Se analiza las posibles discrepancias de medida entre ambos metodos y los factores que influyen en ellas. Material y metodo Se obtuvieron medidas de presion arterial (PA) mediante esfigmomanometro de mercurio, con un monitor Spacelabs, en el mismo brazo y mediante un metodo secuencial. La relacion entre ambas medidas se analizo mediante los coeficientes de correlacion de Pearson y el metodo de Bland y Altman. Se calcularon las diferencias entre ambos metodos de medida. Se analizo los facto…

Blood pressure monitorsbusiness.industryMedicineGeneral MedicineHypertension diagnosisbusinessMercury sphygmomanometerHumanitiesMedicina Clínica
researchProduct

Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring.

2007

To perform a systematic review of the antihypertensive activity of the angiotensin II AT1 receptor antagonists (ARB).Studies in which blood pressure (BP) was measured using ambulatory BP monitoring for at least 24 h were collected from MEDLINE. Data for each treatment group, ARB, placebo or the drug used for its comparison were obtained from the selected studies. Only studies with a minimum of quality criteria were selected. The final study group contained 36 publications, with a total of 47 patient cohorts receiving ARB in monotherapy, 10 with placebo, 10 with amlodipine, and five with enalapril. The reduction in clinical and ambulatory BP during 24 h, day, night and the last 4-h period fo…

Malemedicine.medical_specialtyAmbulatory blood pressurePhysiologyMEDLINEPharmacologyurologic and male genital diseasesEnalaprilInternal medicineInternal MedicinemedicineHumanscardiovascular diseasesAntihypertensive AgentsAngiotensin II receptor type 1Dose-Response Relationship Drugbusiness.industryEprosartanBlood Pressure Monitoring AmbulatoryAngiotensin IIfemale genital diseases and pregnancy complicationsEndocrinologyLosartanValsartanACE inhibitorHypertensionFemaleAmlodipineTelmisartanCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor Blockershormones hormone substitutes and hormone antagonistsmedicine.drugJournal of hypertension
researchProduct

Risk factors associated with retinal vein occlusion

2014

Summary Aims Retinal vein occlusion (RVO) is the most frequent retinal vascular disease after diabetic retinopathy in which arterial risk factors are much more relevant than venous factors. The objective was to evaluate the role of risk factors in the development of the first episode of RVO. Subjects and Methods One hundred patients with RVO [mean age 56 years, 42% females and mean body mass index (BMI) 27.5 kg/m2] were recruited consecutively from the outpatient clinic of a tertiary hospital in Valencia (Spain). All subjects underwent clinical assessment including anthropometric and blood pressure measurements and laboratory test including homocysteine, antiphospholipid antibodies (aPLAs) …

AdultMalemedicine.medical_specialtyPopulationThrombophiliaRisk FactorsInternal medicineRetinal Vein OcclusionPrevalencemedicineHumansThrombophiliaOutpatient clinicObesityeducationAgedDyslipidemiasFirst episodeeducation.field_of_studybusiness.industryVascular diseaseCarotid ultrasonographyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryBlood pressureSpainHypertensionCohortFemalebusinessInternational Journal of Clinical Practice
researchProduct